We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current APYX market cap is 50.58M. The company's latest EPS is USD -0.5402 and P/E is -2.70.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 11.98M | 14.66M | 10.24M | 12.15M | 11.49M |
| Operating Income | -4.64M | -5.78M | -6.62M | -5.55M | -3.64M |
| Net Income | -4.63M | -9.61M | -7.58M | -6.56M | -4.7M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 28.24M | 27.71M | 48.52M | 44.51M | 52.35M |
| Operating Income | -20.87M | -20.08M | -14.45M | -23.56M | -19.95M |
| Net Income | -19.71M | -11.9M | -15.17M | -23.18M | -18.71M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 59.45M | 79.24M | 70.71M | 65.39M | 60.72M |
| Total Liabilities | 25.86M | 52.32M | 50.25M | 50.47M | 49.52M |
| Total Equity | 33.59M | 26.92M | 20.46M | 14.92M | 11.2M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 84.75M | 74.11M | 68.72M | 51.78M | 79.24M |
| Total Liabilities | 13.49M | 10.25M | 14.71M | 13.98M | 52.32M |
| Total Equity | 71.26M | 63.86M | 54.01M | 37.79M | 26.92M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.04M | -5.25M | -6.34M | -10.67M | -15.11M |
| Investing | 6.83M | 6.73M | -35k | -324k | -477k |
| Financing | 8.32M | 32.17M | -5k | -10k | -15k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -18.48M | -16.07M | -10.45M | -20.28M | -5.25M |
| Investing | 60.54M | -581k | -723k | -1.01M | 6.73M |
| Financing | 147k | -73k | 24k | 217k | 32.17M |
| Market Cap | 50.58M |
| Price to Earnings Ratio | -2.70 |
| Price to Sales Ratio | 0.97 |
| Price to Cash Ratio | 1.16 |
| Price to Book Ratio | 1.88 |
| Dividend Yield | - |
| Shares Outstanding | 34.64M |
| Average Volume (1 week) | 21.55k |
| Average Volume (1 Month) | 37.55k |
| 52 Week Change | -34.53% |
| 52 Week High | 2.80 |
| 52 Week Low | 0.967 |
| Spread (Intraday) | 0.44 (26.35%) |
| Company Name | Apyx Medical Corporation |
| Address |
united corporate services, inc dover, delaware 19904 |
| Website | https://www.apyxmedical.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
